The Add-On Effect of Solifenacin for Patients with Remaining Overactive Bladder after Treatment with Tamsulosin for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction

Figure 1

Changes in parameters before and after 2.5 mg and 5.0 mg of solifenacin treatment. White and black circles indicated mean value of 2.5 mg and 5.0 mg of solifenacin, respectively. (a) The IPSS storage symptoms (line) and the IPSS voiding symptoms (dotted lines) 2.5 mg: 𝑛=16, 5.0 mg: 𝑛=32, (b) OABSS, 2.5 mg: 𝑛=16, 5.0 mg: 𝑛=32, and (c) Qmax (line, 2.5 mg: 𝑛=12, 5.0 mg: 𝑛=24) and PVR (dotted lines, 2.5 mg: 𝑛=15, 5.0 mg: 𝑛=30).

(a) IPSS

(b) OABSS

(c) Qmax and PVR